NSE: LAURUSLABS · 29 October 2026
- Laurus Labs Limited shares advanced 2.85% today, trading near the upper end of the session. The stock opened at ₹2,185.10 and touched a day's high of ₹2,244.00, which also marks a new 52-week high, against a low of ₹2,166.50.
- Trading volume was 1.77 times the 20-day average daily volume.
Why is Laurus Labs share price rising on 29 October 2026?
Laurus Labs Limited shares advanced 2.85% today, trading near the upper end of the session. The stock opened at ₹2,185.10 and touched a day's high of ₹2,244.00, which also marks a new 52-week high, against a low of ₹2,166.50.
The broader market and sector backdrop remained supportive during the session. The benchmark Nifty rose 1.05%, while the Nifty Pharma sector index posted a 0.64% gain, indicating positive sentiment across pharmaceutical equities. Laurus Labs' intraday momentum outperformed both the wider market and its sector peers, supported by strong trailing returns of 12.06% over the past 5 trading days and 13.39% over the past 20 trading days.
The upward price action coincided with the release of strong financial results for the quarter and half-year ended September 30, 2026, alongside corporate announcements detailing strategic acquisitions. Laurus Labs reported a 33% year-on-year increase in revenue to ₹2,206 crore and a 126% jump in net profit to ₹441 crore for the quarter, while also announcing definitive agreements to acquire majority stakes in Galenvs Sciences and SI & C Resins to strengthen its CDMO and peptide capabilities.
28.68 lakh shares traded by 29 October 2026 · 03:25 PM IST. This compares with a 20-day average daily volume of 16.23 lakh shares (1.77 times). The five-day average daily volume was 21.22 lakh shares. Separately, the NSE report for 28 October 2026 showed 9.21 lakh shares delivered, representing 41.85% of that day’s traded volume. The same report recorded 66,516 trades.
The stock's 2.85% rise to a new 52-week high on elevated trading volume directly coincides with the public release of financial results showing substantial year-on-year revenue and profit growth, alongside announcements of major strategic acquisitions in the oligonucleotide and peptide spaces.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 8.26% on 30 September 2026. This compares with 10.15% on 30 June 2026, a change of -1.89 percentage points.
The filing reported 38 MF/UTI holders.
Historical Bulk / Block Deals
What to Watch Next
- Execution progress and integration timelines for newly acquired Galenvs Sciences and SI & C Resins
- Ramp-up and commercial utilization rates at the newly inaugurated peptide manufacturing facility in Vizag
- Delivery volume trends and cash market participation relative to the 20-day average volume of 1.77x
- Upcoming interim dividend record date scheduled for November 6, 2026
Other Dated Coverage
- Laurus Labs Share Price Today: Rises 10.76% in 3 Trading Sessions | 28 October 2026 — 28 October 2026
- Laurus Labs Share Price Today: Why LAURUSLABS Is Rising 4.04% | 27 October 2026 — 27 October 2026
- Laurus Labs Share Price Today: Why LAURUSLABS Is Falling 1.94% | 23 October 2026 — 23 October 2026
More Laurus Labs news and dated analysis →
Frequently Asked Questions
How strong was Laurus Labs’s trading volume?
28.68 lakh shares traded, 1.77 times the 20-day average daily volume. The price and volume data are dated 29 October 2026 · 03:25 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.